Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances

Daily Values

Growth Metrics

Novavax (NVAX) Amortizatization of Intangibles (2016 - 2021)

Novavax has reported Amortizatization of Intangibles over the past 8 years, most recently at $951000.0 for Q1 2021.

Quarterly results put Amortizatization of Intangibles at $951000.0 for Q1 2021, changed N/A from a year ago — trailing twelve months through Mar 2021 was $694000.0 (up 274.81% YoY), and the annual figure for FY2016 was -$257000.0, up 78.88%.
Amortizatization of Intangibles for Q1 2021 was $951000.0 at Novavax, up from $6000.0 in the prior quarter.
Over the last five years, Amortizatization of Intangibles for NVAX hit a ceiling of $951000.0 in Q1 2021 and a floor of $6000.0 in Q1 2017.